Finally some claritication of what happened!
"In fact, Mr Diamond says, Antisense almost had a partner for its acromegaly candidate before phase II, but the potential licensee walked away. “The company went through full licensing due diligence with us.” However, it was subsequently decided that the discussions would be put on hold until the completion of the phase II clinical trial."
Until now I my thinking was that we had walked away from an insufficient offer!
should create some interest, page-2
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
